Login / Signup

Dynamics of GLP-1R peptide agonist engagement are correlated with kinetics of G protein activation.

Giuseppe DeganuttiYi-Lynn LiangXin ZhangMaryam KhoshoueiLachlan ClydesdaleMatthew J BelousoffHari VenugopalTin T TruongAlisa GlukhovaAndrew N KellerKaren J GregoryKatie LeachArthur ChristopoulosRadostin DanevChristopher A ReynoldsPeishen ZhaoPatrick M SextonDenise Wootten
Published in: Nature communications (2022)
The glucagon-like peptide-1 receptor (GLP-1R) has broad physiological roles and is a validated target for treatment of metabolic disorders. Despite recent advances in GLP-1R structure elucidation, detailed mechanistic understanding of how different peptides generate profound differences in G protein-mediated signalling is still lacking. Here we combine cryo-electron microscopy, molecular dynamics simulations, receptor mutagenesis and pharmacological assays, to interrogate the mechanism and consequences of GLP-1R binding to four peptide agonists; glucagon-like peptide-1, oxyntomodulin, exendin-4 and exendin-P5. These data reveal that distinctions in peptide N-terminal interactions and dynamics with the GLP-1R transmembrane domain are reciprocally associated with differences in the allosteric coupling to G proteins. In particular, transient interactions with residues at the base of the binding cavity correlate with enhanced kinetics for G protein activation, providing a rationale for differences in G protein-mediated signalling efficacy from distinct agonists.
Keyphrases